The first patient with this specific autoimmunity disorder was identified at CHOP.

Team MATCHMAKERS will focus on the interaction between t cell receptors and cancer antigens.

A 16-week course could increase the threshold of peanut, tree nuts, egg, milk and wheat that would trigger an allergic reaction.

Children’s Hospital of Philadelphia (CHOP) is thrilled to announce a gift of $5 million from the Wyss Foundation to support innovations that improve the lives of patients with thoracic insufficiency syndrome (TIS).

Quick-Mitome, developed by an international consortium of mitochondrial disease specialists, is available for non-commercial, non-clinical research.

This new method, typically used in adult patients, may spare patients from having to undergo open heart surgery.

Researchers from Children’s Hospital of Philadelphia (CHOP) and Johns Hopkins University School of Medicine studied how high levels of substance and polysubstance use are associated with sexual practices, and partner characteristics that can reinforce risk for HIV acquisition or transmission among Black and Latinx sexual youth as well as gender minority youth. 

Children’s Hospital of Philadelphia is proud to announce the initial results of an experimental gene therapy treatment of a patient with hereditary hearing loss in the United States. Findings to date indicate that the treatment was successful.

Vaccination associated with moderate protection in large, diverse cohort.

Data from this method could be used to discover how cancers are able to evade therapy and provide better insight into underlying tumor mechanisms.